Dropless vs. Standard Drops Contralateral Eye Study

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Cataract
Interventions
DRUG

TriMoxiVanc

triamcinolone acetonide 15 mg / ml with moxifloxacin 1 mg/ml, vancomycin 10 mg/ml to be injected at time of cataract surgery.

DRUG

Moxifloxacin HCl 0.5%

Antibiotic to be used 1 drop, QID for 3 days prior to surgery and will continue for 2 weeks after surgery and then discontinue.

DRUG

Ilevro

NSAID to be used 1 drop QD starting 3 days before surgery and QD for 4 weeks after surgery.

DRUG

Prednisolone acetate 1%

Steroid to be started after surgery 1 drop QID for 2 weeks, tapered to BID for 2 weeks, and then discontinued.

Trial Locations (4)

11530

Ophthalmic Consultants of Long Island, Garden City

29464

Carolina Eyecare Physicians, LLC, Mt. Pleasant

55082

Associated Eye Care, Stillwater

55431

Minnesota Eye Consultants, P.A., Bloomington

All Listed Sponsors
collaborator

Science in Vision

OTHER

lead

Carolina Eyecare Physicians, LLC

OTHER

NCT02515045 - Dropless vs. Standard Drops Contralateral Eye Study | Biotech Hunter | Biotech Hunter